J8655 Insurance Policy Changes

Akynzeo (netupitant and palonosetron)

BCBS Mississippi updated their Akynzeo policy, changing language from 'treatment' to 'prevention' of chemotherapy-induced nausea and vomiting, but the drug remains considered not medically necessary. The policy continues to deny coverage for both oral and injection forms due to insufficient evidence of greater clinical benefit compared to other available treatment options.